We recently reported that the engagement between tNOX and oxaliplatin, which is a platinum-based drug that is used clinically to treat cancer, contributes to inhibiting tNOX and inducing apoptosis in colon cancer cells [41]. Here, ENOX2 is linked to colonic neoplasm.